Is the third-line chemotherapy feasible for non-small cell lung cancer? A retrospective study.

MLA

Özdogan, Mustafa, et al. “Is the Third-Line Chemotherapy Feasible for Non-Small Cell Lung Cancer? A Retrospective Study.” Turkish Journal of Cancer, vol. 34, no. 1, Jan. 2004, pp. 19–23. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=12844814&authtype=sso&custid=ns315887.

APA

Özdogan, M., Samur, M., Bozcuk, H., Çoban, E., Artaç, M., & Savas, B. (2004). Is the third-line chemotherapy feasible for non-small cell lung cancer? A retrospective study. Turkish Journal of Cancer, 34(1), 19–23.

Chicago

Özdogan, Mustafa, Mustafa Samur, Hakan Bozcuk, Erkan Çoban, Mehmet Artaç, and Burhan Savas. 2004. “Is the Third-Line Chemotherapy Feasible for Non-Small Cell Lung Cancer? A Retrospective Study.” Turkish Journal of Cancer 34 (1): 19–23. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=12844814&authtype=sso&custid=ns315887.